Oxford Vaccine Group - Home — Oxford Vaccine Group

Our Mission

To drive scientific discovery, develop innovative vaccines, and share knowledge that delivers lasting impact for all.

Find out more ❯

Latest News

The University of Oxford has launched the world’s first Phase II clinical trial of a Nipah virus vaccine candidate.

World's first Phase II Nipah virus vaccine trial launch

The first volunteer has received a dose in a first-in-human trial of Oxford’s Lassa vaccine, marking a major milestone in the fight against the deadly virus. The trial, conducted by the Oxford Vaccine Group, and funded by the Coalition for Epidemic Preparedness Innovations (CEPI), will assess the safety and immune response of the ChAdOx1 Lassa vaccine. 31 people aged 18-55 will participate in the trial in total.

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

A new international network of social scientists, the Forum for Vaccine Social Science (FoVaS), is calling for a fundamental rethink of how vaccines and vaccination are studied in society.

Public scepticism of vaccination is rising- social scientists call for a rethink of research

More news ❯

Be part of the story.

Join 30 years of vaccine research that saves lives and find a study that suits you.

Find your study ❯

Protecting children worldwide

10 million doses of a typhoid conjugate vaccine we tested were used to stop an outbreak of extraordinarily resistant typhoid in Pakistan in 2019.

_{learn more ❯}

Responding to global crises

The Oxford-AstraZeneca vaccine saved 6.3 million lives in the first year of the global vaccine rollout during the COVID-19 pandemic.

_{learn more ❯}

Join the team.

Whether you work at the bench, the bedside, or somewhere in between, you can play a vital role in advancing vaccine science.

Explore our current vacancies and DPhil opportunities, and take your next step in shaping the future of vaccines with us.

Work with us ❯

Study with us ❯

Current Studies

Mucosal Study

Help us investigate the response of cells in the nose, lung and blood after respiratory infections
ECLIPSE

A study to understand how the body reacts to a combination of the flu virus and pneumococcal bacteria.
BIO-005 Malaria Vaccine and Challenge Study

Help us find a safe and effective malaria vaccine!
ViTaL01

Help us prevent deadly outbreaks of Lassa fever
BiVISTA

Could you be a part of the battle against Typhoid and Paratyphoid fever?
LEGACY04

Help improve the understanding of immune responses to vaccination
NAVIGATE

Understanding public opinion on vaccinating teenagers against gonorrhoea